Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02478190 · ClinicalTrials.gov registry record · NA
ED Management of Severe Hyperglycemia: A Clinical Trial
A NA study, sponsored by Hennepin Healthcare Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT02478190 is a NA study that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 110 participants.
The verdict
NCT02478190, a NA study, has completed, sponsored by Hennepin Healthcare Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
Emergency Department (ED) patients with severe hyperglycemia will be randomized to two treatment goals: discharge glucose less than 600 mg/dL or less than 350 mg/dL. Randomization is stratified by whether the chief complaint is "High Blood Sugar" in the electronic medical record or other.
Interventions
- OTHER Tight control: goal glucose 350 mg/dL or lower
- OTHER Loose control: goal glucose 600 mg/dL or lower
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02478190
The ClinicalTrials.gov registry entry for NCT02478190 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tight control: goal glucose 350 mg/dL or lower is the first listed.
NCT02478190 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02478190 about?
NCT02478190 is a clinical study titled "ED Management of Severe Hyperglycemia: A Clinical Trial". Emergency Department (ED) patients with severe hyperglycemia will be randomized to two treatment goals: discharge glucose less than 600 mg/dL or less than 350 mg/dL. Randomization is stratified by whether the chief complaint is "High Blood Sugar" in the electronic medical record or other.
What is the current status of trial NCT02478190?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2015-06. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02478190?
The interventions under investigation include: Tight control: goal glucose 350 mg/dL or lower (OTHER), Loose control: goal glucose 600 mg/dL or lower (OTHER).
Who is sponsoring clinical trial NCT02478190?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.